This new study, formally called Starting Antiretroviral Therapy at Three Points in Tuberculosis (SAPIT), explored when is the best time to begin ART during the anti-TB treatment in people co-infected with HIV and TB. It found that beginning ART in TB-HIV co-infected patients with a CD4 count of less than 50 cells/ mm3 reduced the death rate by 68 per cent.
At the 2010 XVIII International AIDS Conference held in Vienna, Austria, world's leading scientists had spoken to CNS and the message was clear: Putting TB-HIV co-infected people on the anti-retroviral therapy (ART) slows down HIV progression to AIDS.
The positive health outcomes of starting antiretroviral therapy (ART) in TB-HIV co-infected people are undisputed – regardless of their CD4 count – because it slows down HIV progression to AIDS.
The positive health outcomes of starting antiretroviral therapy (ART) in TB-HIV co-infected people are undisputed – regardless of their CD4 count – because it slows down HIV progression to AIDS.
In high burden countries, there is a need to test all TB patients for HIV (through provider initiated HIV testing) and of those HIV-positive who test positive for active TB disease, we must provide immediate cotrimoxazole preventive therapy, anti-TB therapy and ART as soon as possible.
Bobby Ramakant - CNS
Great news indeed. Keep up the good work.
ReplyDeleteBuy Generic Viagra
Great review on HIV for review, You have made great content for to avoid any problem@
ReplyDeleteHave a great healthy life, Thank you
Integrated medication should be specified when both conditions exist. If not, then the medication should only be limited to the illness.
ReplyDeleteProper health procedures have to be followed. A Double Bay Dentist can also help maintain dental health.
ReplyDelete